Details for New Drug Application (NDA): 078112
✉ Email this page to a colleague
NDA 078112 describes DIDANOSINE, which is a drug marketed by Aurobindo Pharma, Barr, Norvium Bioscience, and Aurobindo, and is included in five NDAs. Additional details are available on the DIDANOSINE profile page.
The generic ingredient in DIDANOSINE is didanosine. There are eight drug master file entries for this compound. Additional details are available on the didanosine profile page.
The generic ingredient in DIDANOSINE is didanosine. There are eight drug master file entries for this compound. Additional details are available on the didanosine profile page.
Summary for 078112
| Tradename: | DIDANOSINE |
| Applicant: | Aurobindo Pharma |
| Ingredient: | didanosine |
| Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 078112
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | FOR SOLUTION;ORAL | Strength | 10MG/ML | ||||
| Approval Date: | Mar 8, 2007 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
